Switzerland· 56998001

Naabak, collyre

A spagluminsäure product containing natrii n-acetyl-aspartylglutamas, registered in Switzerland by THEA Pharma S.A. and dispensed under Swissmedic category B, on the national reimbursement list.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC S01GX03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNaabak, collyreATCS01GX03REGISTER NO.56998001PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
natrii N-acetyl-aspartylglutamas
Manufacturer
THEA Pharma S.A.
Country
Switzerland (CH)
ATC code
S01GX03
ATC class
Spagluminsäure
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680569980017
    10 ml
    CHF 15.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df1f000a-f824-4258-8e41-87448d48b1dc
GET /v1/drugs/df1f000a-f824-4258-8e41-87448d48b1dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "natrii n-acetyl-aspartylglutamas 49 mg",
  "valid_from": "2008-09-01",
  "limitations": null,
  "galenic_form": "Gtt Opht",
  "therapeutic_area": null,
  "sl_inclusion_date": "2008-09-01",
  "self_retention_pct": 10
}

See everything about spagluminsäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.